InflaRx NV (IFRX)
2.04
-0.06
(-2.86%)
USD |
NASDAQ |
Aug 24, 16:00
2.04
0.00 (0.00%)
After-Hours: 20:00
InflaRx 1 Year Total Returns (Daily) : 133.9% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | 133.9% |
| August 20, 2026 | 126.2% |
| August 19, 2026 | 140.3% |
| August 18, 2026 | 138.9% |
| August 17, 2026 | 139.9% |
| August 14, 2026 | 146.6% |
| August 13, 2026 | 146.3% |
| August 12, 2026 | 141.3% |
| August 11, 2026 | 143.0% |
| August 10, 2026 | 144.9% |
| August 07, 2026 | 125.7% |
| August 06, 2026 | 104.8% |
| August 05, 2026 | 101.1% |
| August 04, 2026 | 100.4% |
| August 03, 2026 | 103.5% |
| July 31, 2026 | 87.85% |
| July 30, 2026 | 95.45% |
| July 29, 2026 | 88.79% |
| July 28, 2026 | 92.72% |
| July 27, 2026 | 89.16% |
| July 24, 2026 | 104.7% |
| July 23, 2026 | 101.4% |
| July 22, 2026 | 113.1% |
| July 21, 2026 | 111.2% |
| July 20, 2026 | 110.6% |
| Date | Value |
|---|---|
| July 17, 2026 | 113.7% |
| July 16, 2026 | 124.7% |
| July 15, 2026 | 148.2% |
| July 14, 2026 | 125.3% |
| July 13, 2026 | 134.1% |
| July 10, 2026 | 129.0% |
| July 09, 2026 | 130.4% |
| July 08, 2026 | 146.6% |
| July 07, 2026 | 158.5% |
| July 06, 2026 | 163.0% |
| July 02, 2026 | 176.2% |
| July 01, 2026 | 191.2% |
| June 30, 2026 | 183.5% |
| June 29, 2026 | 182.2% |
| June 26, 2026 | 130.6% |
| June 25, 2026 | 121.4% |
| June 24, 2026 | 141.2% |
| June 23, 2026 | 143.4% |
| June 22, 2026 | 138.9% |
| June 18, 2026 | 126.8% |
| June 17, 2026 | 136.4% |
| June 16, 2026 | 105.1% |
| June 15, 2026 | 106.6% |
| June 12, 2026 | 100.0% |
| June 11, 2026 | 101.7% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| MediGene AG | 0.00% |
| BioNTech SE | 5.24% |
| Immatics NV | 58.61% |
| Beam Therapeutics, Inc. | 85.88% |
| Kymera Therapeutics, Inc. | 181.3% |